跳至主要内容
临床试验/NCT06683469
NCT06683469已完成不适用

Neutrophil-to-Lymphocyte Ratio in Predicting Outcomes of Patients With Aneurysmal Subarachnoid Hemorrhage in a Tertiary Care Hospital in Nepal

Sujan Paudel1 个研究点 分布在 1 个国家目标入组 51 人开始时间: 2022年6月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
51
试验地点
1
主要终点
mRS score

研究概览

简要总结

This study uses Neutrophil-to-Lymphocyte Ratio to Predict Outcomes of Patients with Aneurysmal Subarachnoid Hemorrhage which will be beneficial in taking early decisions for surgery , patient counselling etc

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients > 18 years of age, of either genders, ethnicity and location who presented to the emergency department within 72 hours of the onset of symptoms who underwent surgical or interventional treatment for SAH caused by a ruptured intracranial aneurysm

排除标准

  • excluded patients with traumatic SAH, history of infection or stroke within eight weeks, underlying cancer, severe kidney or liver disease, history of auto-immune or hematologic disorder lost to follow-up within three months and individuals declining informed consent.

结局指标

主要结局

mRS score

时间窗: 3 months

次要结局

未报告次要终点

研究者

发起方
Sujan Paudel
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Sujan Paudel

Dr

Maharajgunj Medical Campus

研究点 (1)

Loading locations...

相似试验